About Blirt
Blirt is a company based in Gdansk (Poland) founded in 2008 by Marian Popinigis was acquired by Qiagen in May 2022. Blirt offers products and services including Proteinase K and RNase Inhibitor. Blirt operates in a competitive market with competitors including Abcam, Stem Cell Technologies, GenScript, Sino Biological and Miltenyi Biotec, among others.
- Headquarter Gdansk, Poland
- Founders Marian Popinigis
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Blirt S.A.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Blirt
Blirt offers a comprehensive portfolio of products and services, including Proteinase K and RNase Inhibitor.
High-demand enzyme for protein digestion in molecular biology assays
Protects RNA from degradation during biological research applications
Funding Insights of Blirt
Detailed funding history for Blirt
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Blirt
Blirt has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Qiagen.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Products and reagents for molecular diagnostic assays are supplied.
|
Locked | Locked | Locked |
Investor details for Blirt
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Blirt
Investment portfolio details for Blirt
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Blirt
Detailed financials for Blirt
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Blirt Comparisons
Peer comparison for Blirt
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Blirt
Blirt operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Abcam, Stem Cell Technologies, GenScript, Sino Biological and Miltenyi Biotec, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Biological reagents and antibodies are developed for life science research.
|
|
| Locked | Locked | Locked |
Developer of cell culture media and ancillary reagents for life science research
|
|
| Locked | Locked | Locked |
Reagents and instruments are provided for life sciences research.
|
|
| Locked | Locked | Locked |
Reagents and kits are provided for clinical research applications.
|
|
| Locked | Locked | Locked |
Develops tools and products for research and clinical application
|
|
| Locked | Locked | Locked |
Provider of molecular diagnostic kits for cancer, hereditary diseases, and reproductive disorders
|
Detailed competitors of Blirt
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Blirt
Complete news archive for Blirt
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Blirt
Blirt was founded in 2008.
Blirt is headquartered in Gdansk, Poland. It is registered at Gdansk, Pomeranian Voivodeship, Poland.
Piotr Lassota is the current CEO of Blirt.
BLIRT was established in 2008 in Gdansk, Poland, within the biotechnology sector. Specialty enzymes used in nucleic acid purification and sequencing are manufactured by the company. Molecular biology kits are supplied alongside these products. Protein production services are offered, encompassing the design of expression systems for commercial applications. Operations remain focused on enzyme and kit development in Europe.
Blirt's top competitors include Abcam, Sino Biological and Meridian Bioscience.
Blirt offers Proteinase K and RNase Inhibitor.
Blirt has 1 investor. Key investors include Qiagen.